# Celgene International Sarl – FDA Inspection, Jun 16, 2023

Source: https://www.keypedia.com/records/fda_inspections/celgene-international-sarl/703b6419-2885-43fd-92f9-2585af03706d
Source feed: FDA_Inspections

> FDA inspection 1208191 of Celgene International Sarl, June 16, 2023. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1208191
- Company Name: Celgene International Sarl
- Inspection Date: 2023-06-16
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- [FDA Inspection 1026576 - 2017-09-15](https://www.keypedia.com/records/fda_inspections/celgene-international-sarl/297260ba-3a39-4228-8ca4-e7527149ae6f)
- FDA Inspection 854856 - 2013-10-25
- FDA Inspection 773948 - 2012-03-08
- FDA Inspection 618709 - 2009-09-04

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/camerson-e-moore/50733244-0d55-4b0b-a758-f192b7c66457)

Company: https://www.keypedia.com/companies/celgene-international-sarl/4b6c72e0-737a-445e-a238-7c7cc1265e65

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
